Asthma Rescue Drug & Delivery Device
In Phase II Clinical Trials
SolAeroMed is a company dedicated to the development of novel therapeutic strategies to treat obstructive lung diseases. Our lead asthma drug, S-1226, is in Phase II clinical trials designed to demonstrate Proof of Concept.
SolAeroMed management and clinicians have a number of upcoming conferences it will be attending. Please visit our News & Events page for more details.